Management of gastrointestinal angiodysplastic lesions (GIADs): A systematic review and meta-analysis

American Journal of Gastroenterology

Volumn 109, Issue 4, 2014, Pages 474-483

  Jackson, Christian S ^a   Gerson, Lauren B ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; THALIDOMIDE;

ANGIODYSPLASIA; AORTA VALVE REPLACEMENT; ARGON PLASMA COAGULATION; BLEEDING; CASE CONTROL STUDY; CLINICAL EFFECTIVENESS; COLON DISEASE; ENDOSCOPIC THERAPY; FOLLOW UP; GASTROINTESTINAL ANGIODYSPLASTIC LESION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SURGERY; HORMONAL THERAPY; HUMAN; LOW LEVEL LASER THERAPY; META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; RECURRENT DISEASE; REVIEW; SMALL INTESTINE DISEASE; STOMACH DISEASE; SYSTEMATIC REVIEW;

ANGIODYSPLASIA; ANGIOGENESIS INHIBITORS; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL HEMORRHAGE; HEART VALVE PROSTHESIS IMPLANTATION; HEMOSTASIS, ENDOSCOPIC; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; MODELS, STATISTICAL; OCTREOTIDE; ODDS RATIO; RECURRENCE; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 84897992487     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.19     Document Type: Review

References (63)

1. Boley SJ, Sammartano R, Adams A et al. On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of aging. Gastroenterology 1977; 72: 650-60.
2. Junquera F, Saperas E, de Torres I et al. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol 1999; 94: 1070-6.
3. Foutch PG, Rex DK, Lieberman DA. Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol 1995; 90: 564-7.
4. Clouse RE, Costigan DJ, Mills BA et al. Angiodysplasia as a cause of upper gastrointestinal bleeding. Arch Intern Med 1985; 145: 458-61.
5. Cappell MS. Spatial clustering of simultaneous nonhereditary gastrointestinal angiodysplasia. Small but significant correlation between nonhereditary colonic and upper gastrointestinal angiodysplasia. Dig Dis Sci 1992; 37: 1072-7.
6. Hochter W, Weingart J, Kuhner W et al. Angiodysplasia in the colon and rectum. Endoscopic morphology, localisation and frequency. Endoscopy 1985; 17: 182-5.
7. Danesh BJ, Spiliadis C, Williams CB et al. Angiodysplasia-An uncommon cause of colonic bleeding: Colonoscopic evaluation of 1,050 patients with rectal bleeding and anaemia. Int J Colorectal Dis 1987; 2: 218-22.
8. Savides TJ, Jensen DM, Cohen J et al. Severe upper gastrointestinal tumor bleeding: Endoscopic findings, treatment, and outcome. Endoscopy 1996; 28: 244-8.
9. Moreto M, Figa M, Ojembarrena E et al. Vascular malformations of the stomach and duodenum: An endoscopic classification. Endoscopy 1986; 18: 227-9.
10. Raju GS, Gerson L, Das A et al. American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding. Gastroenterology 2007; 133: 1694-6.
11. DeBenedet AT, Saini SD, Takami M et al. Do clinical characteristics predict the presence of small bowel angioectasias on capsule endoscopy?. Dig Dis Sci 2011; 56: 1776-81.
12. Lewis BS, Salomon P, Rivera-MacMurray S et al. Does hormonal therapy have any benefit for bleeding angiodysplasia?. J Clin Gastroenterol 1992; 15: 99-103.
13. Junquera F, Feu F, Papo M et al. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001; 121: 1073-9.
14. Gerson LB, Batenic MA, Newsom SL et al. Long-Term outcomes aft er double-balloon enteroscopy for obscure gastrointestinal bleeding. Clin Gastroenterol Hepatol 2009; 7: 664-9.
15. Shinozaki S, Yamamoto H, Yano T et al. Long-Term outcome of patients with obscure gastrointestinal bleeding investigated by double-balloon endoscopy. Clin Gastroenterol Hepatol 2010; 8: 151-8.
16. Hsu CM, Chiu CT, Su MY et al. The outcome assessment of double-balloon enteroscopy for diagnosing and managing patients with obscure gastrointestinal bleeding. Dig Dis Sci 2007; 52: 162-6.
17. Cello JP, Grendell JH. Endoscopic laser treatment for gastrointestinal vascular ectasias. Ann Intern Med 1986; 104: 352-4.
18. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12.
19. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-Analyses. Eur J Epidemiol 2010; 25: 603-5.
20. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in metaanalyses. BMJ 2003; 327: 557-60.
21. DerSimonian R, Laird N. Meta-Analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
23. Egger M, Davey Smith G, Schneider M et al. Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
24. Kwan V, Bourke MJ, Williams SJ et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: Experience in 100 consecutive patients with long-Term follow-up. Am J Gastroenterol 2006; 101: 58-63.
25. Vakil N, Huilgol V, Khan I. effect of push enteroscopy on transfusion requirements and quality of life in patients with unexplained gastrointestinal bleeding. Am J Gastroenterol 1997; 92: 425-8.
26. Askin MP, Lewis BS. Push enteroscopic cauterization: Long-Term follow-up of 83 patients with bleeding small intestinal angiodysplasia. Gastrointest Endosc 1996; 43: 580-3.
27. Lewis BS, Salomon P, Rivera-MacMurray S et al. Does hormonal therapy have any benefit for bleeding angiodysplasia?. J Clin Gastroenterol 1992; 15: 99-103.
28. Szilagyi A, Ghali MP. Pharmacological therapy of vascular malformations of the gastrointestinal tract. Can J Gastroenterol 2006; 20: 171-8.
29. Tulassay Z. Somatostatin and the gastrointestinal tract. Scand J Gastroenterol Suppl 1998; 228: 115-21.
30. Scarpignato C, Pelosini I. Somatostatin for upper gastrointestinal hemorrhage and pancreatic surgery. A review of its pharmacology and safety. Digestion 1999; 60 (Suppl 3): 1-16.
31. Kubba AK, Dallal H, Haydon GH et al. The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man. Am J Gastroenterol 1999; 94: 1077-82.
32. Lamberts SW, van der Lely AJ, de Herder WW et al. Octreotide. N Engl J Med 1996; 334: 246-54.
33. Barrie R, Woltering EA, Hajarizadeh H et al. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J Surg Res 1993; 55: 446-50.
34. Eriksson LS, Wahren J. Intravenous and subcutaneous administration of a longacting somatostatin analogue: Effects on glucose metabolism and splanchnic haemodynamics in healthy subjects. Eur J Clin Invest 1989; 19: 213-9.
35. Brown C, Subramanian V, Wilcox CM et al. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: An overview and systematic review of prospective observational studies. Dig Dis Sci 2010; 55: 2129-34.
36. Bon C, Aparicio T, Vincent M et al. Long-Acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia. Aliment Pharmacol Ther 2012; 36: 587-93.
37. Junquera F, Saperas E, Videla S et al. Long-Term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am J Gastroenterol 2007; 102: 254-60.
38. Scaglione G, Pietrini L, Russo F et al. Long-Acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia. Aliment Pharmacol Ther 2007; 26: 935-42.
39. Nardone G, Rocco A, Balzano T et al. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999; 13: 1429-36.
40. Ge ZZ, Chen HM, Gao YJ et al. efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 2011; 141: 1629-37 e1-4.
41. Garrido A, Sayago M, Lopez J et al. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias. Rev Esp Enferm Dig 2012; 104: 69-71.
42. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: Is acquired von Willebrand's disease the link?. Lancet 1992; 340: 35-7.
43. Douard R, Wind P, Panis Y et al. Intraoperative enteroscopy for diagnosis and management of unexplained gastrointestinal bleeding. Am J Surg 2000; 180: 181-4.
44. Ress AM, Benacci JC, Sarr MG. efficacy of intraoperative enteroscopy in diagnosis and prevention of recurrent, occult gastrointestinal bleeding. Am J Surg 1992; 163: 94-8; discussion 98-9.
45. King RM, Pluth JR, Giuliani ER. The association of unexplained gastrointestinal bleeding with calcifi c aortic stenosis. Ann Thorac Surg 1987; 44: 514-6.
46. Veyradier A, Balian A, Wolf M et al. Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract. Gastroenterology 2001; 120: 346-53.
47. Hoog CM, Brostrom O, Lindahl TL et al. Bleeding from gastrointestinal angioectasias is not related to bleeding disorders-A case control study. BMC Gastroenterol 2010; 10: 113.
48. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
49. Chey WD, Hasler WL, Bockenstedt PL. Angiodysplasia and von Willebrand's disease type IIB treated with estrogen/progesterone therapy. Am J Hematol 1992; 41: 276-9.
50. Inbal A, Bank I, Zivelin A et al. Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor. Br J Haematol 1997; 96: 179-82.
51. Fan GW, Chen TH, Lin WP et al. Angiodysplasia and bleeding in the small intestine treated by balloon-Assisted enteroscopy. J Dig Dis 2013; 14: 113-6.
52. Samaha E, Rahmi G, Landi B et al. Long-Term outcome of patients treated with double balloon enteroscopy for small bowel vascular lesions. Am J Gastroenterol 2012; 107: 240-6.
53. May A, Friesing-Sosnik T, Manner H et al. Long-Term outcome aft er argon plasma coagulation of small-bowel lesions using double-balloon enteroscopy in patients with mid-gastrointestinal bleeding. Endoscopy 2011; 43: 759-65.
54. Godeschalk MF, Mensink PB, van Buuren HR et al. Primary balloonassisted enteroscopy in patients with obscure gastrointestinal bleeding: Findings and outcome of therapy. J Clin Gastroenterol 2010; 44: E195-200.
55. Saperas E, Videla S, Dot J et al. Risk factors for recurrence of acute gastrointestinal bleeding from angiodysplasia. Eur J Gastroenterol Hepatol 2009; 21: 1333-9.
56. Olmos JA, Marcolongo M, Pogorelsky V et al. Long-Term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia. Dis Colon Rectum 2006; 49: 1507-16.
57. Olmos JA, Marcolongo M, Pogorelsky V et al. Argon plasma coagulation for prevention of recurrent bleeding from GI angiodysplasias. Gastrointest Endosc 2004; 60: 881-6.
58. Hayat M, Axon AT, O'Mahony S. Diagnostic yield and effect on clinical outcomes of push enteroscopy in suspected small-bowel bleeding. Endoscopy 2000; 32: 369-72.
59. Schmit A, Gay F, Adler M et al. Diagnostic efficacy of push-enteroscopy and long-Term follow-up of patients with small bowel angiodysplasias. Dig Dis Sci 1996; 41: 2348-52.
60. Gupta N, Longo WE, Vernava AM III. Angiodysplasia of the lower gastrointestinal tract: An entity readily diagnosed by colonoscopy and primarily managed nonoperatively. Dis Colon Rectum 1995; 38: 979-82.
61. Lanthier P, d'Harveng B, Vanheuverzwyn R et al. Colonic angiodysplasia. Follow-up of patients aft er endoscopic treatment for bleeding lesions. Dis Colon Rectum 1989; 32: 296-8.
62. Rutgeerts P, Van Gompel F, Geboes K et al. Long term results of treatment of vascular malformations of the gastrointestinal tract by neodymium Yag laser photocoagulation. Gut 1985; 26: 586-93.
63. Thompson JL III, Schaff HV, Dearani JA et al. Risk of recurrent gastrointestinal bleeding aft er aortic valve replacement in patients with Heyde syndrome. J Thorac Cardiovasc Surg 2012; 144: 112-6.